Pramipexole Related Compound D

C₁₀H₁₇N₃S · 2HCl

284.25

MFCD13186799

329750929

NA.24

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

R-(+)-Pramipexole is a neuroprotective agent; weak non-ergoline dopamine agonist. R-(+)-Pramipexole has been found to have neuroprotective effects and is being investigated for treatment of ALS. It reduces mitochondrial reactive oxygen species (ROS) production, inhibits the activation of apoptotic pathways, and increase cell survival in response to a variety of neurotoxins and β-amyloid neurotoxicity. Compared to the S-(-) isomer, R-(+)-Pramipexole has much lower dopamine agonist activity.

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

USP issued SDS can be found here.
Sales restrictions may apply.

pharmaceutical primary standard

USP

pharmaceutical (small molecule)

neat

Cl.Cl.CCCN[C@@H]1CCc2nc(N)sc2C1

1S/C10H17N3S.2ClH/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H/t7-;;/m1../s1

QMNWXHSYPXQFSK-XCUBXKJBSA-N

GHS07

Warning

H302

P301 + P312 + P330

Acute Tox. 4 Oral

13 - Non Combustible Solids

WGK 3